April 26th 2024
Learn how a mandatory elective single-embryo transfer policy in publicly funded in vitro fertilization programs significantly decreases multifetal pregnancy rates, offering insights into mitigating risks in assisted reproduction.
23rd Annual International Congress on the Future of Breast Cancer® East
July 19-20, 2024
Register Now!
Expert Illustrations & Commentaries™: Targeting Immune Cells to Treat Multiple Sclerosis
View More
15th Annual International Symposium on Ovarian Cancer and Other Gynecologic Malignancies™
May 11, 2024
View More
Community Practice Connections™: 14th Annual International Symposium on Ovarian Cancer and Other Gynecologic Malignancies
View More
4th Annual International Congress on the Future of Women’s Health™
View More
Patient, Provider, and Caregiver Connection™: Exploring Unmet Needs In Postpartum Depression – Making the Case for Early Detection and Novel Treatments
View More
Identifying Health Care Inequities in Screening, Diagnosis, and Trial Access for Breast Cancer Care: Taking Action With Evidence-Based Solutions
View More
Treating “Religious Infertility”
January 27th 2012Orthodox Jewish women may follow an ancient tradition that requires sexual abstention during her menses and for the seven days that follow. Once the woman has completed the period of sexual abstention she immerses in a ritual bath to purify her soul and then is encouraged to have intercourse with her husband but when your patient experiences infertility, how do you treat the infertility while maintaining respect for her religious traditions?
Read More
Addition of Bevacizumab to Ovarian Cancer Treatment is Associated With Better Survival
January 8th 2012Two new studies published in the New England Journal of Medicine point to the importance of using bevacizumab in the treatment of ovarian cancer. Bevacizumab, a recombinant humanized monoclonal antibody directed against the vascular endothelial growth factor, has shown single-agent activity in women with recurrent tumors.
Read More
New Risks for Women with Endometriosis
January 3rd 2012Endometriosis affects as many as 6% of the general population. While some women with endometriosis remain asymptomatic, many women experience dysmenorrhea, dyspareunia, non-cyclical pelvic pain, and subfertility. Now, new research indicates that patients with endometriosis are also more likely to develop inflammatory bowel disease.
Read More
Does Assisted Conception Lead to Increased Risk of Preeclampsia?
December 13th 2011As infertility rates have increased, now affecting as many as 12% of the reproductive age population, so has the use of assisted conception. For instance, in vitro fertilization was employed in about 1% of all live births in the United States.
Read More
Are Patients With Chronic Inflammatory Disease at Risk for Early Menopause?
December 6th 2011Lead researcher Dr Janet McLaren discusses the results of a new study exploring new concerns that rheumatoid arthritis, lupus, and inflammatory bowel disease may lead to premature ovarian failure and early menopause.
Read More
PCOS: What is the Diagnostic Criteria?
OBGYN.net Conference Coveragefrom the 19th Annual Meeting of ESHRE - Madrid, Spain
Read More